+

IT1397566B1 - Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso - Google Patents

Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso

Info

Publication number
IT1397566B1
IT1397566B1 ITRM2009A000270A ITRM20090270A IT1397566B1 IT 1397566 B1 IT1397566 B1 IT 1397566B1 IT RM2009A000270 A ITRM2009A000270 A IT RM2009A000270A IT RM20090270 A ITRM20090270 A IT RM20090270A IT 1397566 B1 IT1397566 B1 IT 1397566B1
Authority
IT
Italy
Prior art keywords
bacteriocines
manufacturer
food
pharmaceutical compositions
same
Prior art date
Application number
ITRM2009A000270A
Other languages
English (en)
Inventor
Luca Mogna
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ITRM2009A000270A priority Critical patent/IT1397566B1/it
Application filed by Probiotical Spa filed Critical Probiotical Spa
Priority to ES10730508.8T priority patent/ES2534750T3/es
Priority to AU2010252656A priority patent/AU2010252656B2/en
Priority to BRPI1011277A priority patent/BRPI1011277B8/pt
Priority to PCT/IB2010/001290 priority patent/WO2010136891A1/en
Priority to PL10730508T priority patent/PL2435056T3/pl
Priority to CN201080033176.7A priority patent/CN102458426B/zh
Priority to RU2011150659/10A priority patent/RU2547599C2/ru
Priority to JP2012512470A priority patent/JP2012527884A/ja
Priority to EP10730508.8A priority patent/EP2435056B1/en
Priority to US13/322,795 priority patent/US9185927B2/en
Publication of ITRM20090270A1 publication Critical patent/ITRM20090270A1/it
Application granted granted Critical
Publication of IT1397566B1 publication Critical patent/IT1397566B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/167Pentosus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ITRM2009A000270A 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso IT1397566B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
AU2010252656A AU2010252656B2 (en) 2009-05-27 2010-05-27 Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
BRPI1011277A BRPI1011277B8 (pt) 2009-05-27 2010-05-27 produto de bacteriocina lactobacillus pentosus, alimento e composições farmacêuticas contendo o mesmo e uso do mesmo
PCT/IB2010/001290 WO2010136891A1 (en) 2009-05-27 2010-05-27 Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
ES10730508.8T ES2534750T3 (es) 2009-05-27 2010-05-27 Lactobacillus pentosus que produce bacteriocinas y uso del mismo en composiciones alimentarias y farmacéuticas
PL10730508T PL2435056T3 (pl) 2009-05-27 2010-05-27 Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych
CN201080033176.7A CN102458426B (zh) 2009-05-27 2010-05-27 产生细菌素的戊糖乳杆菌及其在食品和药物组合物中的应用
RU2011150659/10A RU2547599C2 (ru) 2009-05-27 2010-05-27 Бактериоцин-продуцирующий lactobacillus pentosus и его применение в пищевых и фармацевтических композициях
JP2012512470A JP2012527884A (ja) 2009-05-27 2010-05-27 バクテリオシン産生ラクトバチルス・ペントーサスならびに食品および医薬組成物におけるその使用
EP10730508.8A EP2435056B1 (en) 2009-05-27 2010-05-27 Bacteriocin-producing lactobacillus pentosus and the use thereof in food and pharmaceutical compositions
US13/322,795 US9185927B2 (en) 2009-05-27 2010-05-27 Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso

Publications (2)

Publication Number Publication Date
ITRM20090270A1 ITRM20090270A1 (it) 2010-11-28
IT1397566B1 true IT1397566B1 (it) 2013-01-16

Family

ID=41434751

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2009A000270A IT1397566B1 (it) 2009-05-27 2009-05-27 Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso

Country Status (11)

Country Link
US (1) US9185927B2 (it)
EP (1) EP2435056B1 (it)
JP (1) JP2012527884A (it)
CN (1) CN102458426B (it)
AU (1) AU2010252656B2 (it)
BR (1) BRPI1011277B8 (it)
ES (1) ES2534750T3 (it)
IT (1) IT1397566B1 (it)
PL (1) PL2435056T3 (it)
RU (1) RU2547599C2 (it)
WO (1) WO2010136891A1 (it)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110679A1 (it) * 2011-04-20 2012-10-21 Giovanni Mogna Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITRM20110475A1 (it) * 2011-09-09 2013-03-10 Probiotical Spa Ceppi di batteri lattici e/o bifido batteri, opzionalmente addizionati di n-acetilcisteina e/o lisozima microincapsulato gastroprotetto, aventi attivita' di inibizione/riduzione della crescita di differenti biotipi di e.coli, incluso e.coli o157:h7 e
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
JP2013150599A (ja) * 2011-12-27 2013-08-08 Nihon Univ 抗菌物質生産菌と発酵菌を共培養する発酵法
ITMI20122270A1 (it) * 2012-12-31 2014-07-01 Giovanni Mogna Terapia di supporto ai trattamenti di chemioterapia per i tumori, per la sindrome da immunodeficienza acquisita e per le leucemie.
KR20150143804A (ko) * 2013-04-17 2015-12-23 산토리 홀딩스 가부시키가이샤 락토바실러스속 균
ES2684074T3 (es) 2013-04-17 2018-10-01 Suntory Holdings Limited Composición que contiene una bacteria que pertenece al género Lactobacillus
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130792A1 (it) * 2013-05-14 2014-11-15 Mofin S R L Metodo per la prevenzione e/o riduzione dello sviluppo della listeria nell'industria casearia e prevenzione della listeriosi nell'uomo.
LT6142B (lt) 2013-05-15 2015-04-27 Uab "Biocentras" Sėklinių grūdų ir sėklų apdorojimo būdas
TWI643626B (zh) * 2013-08-12 2018-12-11 西班牙商巨妮亞實驗室有限公司 作為益生菌之乳桿菌屬菌株
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CN106754506B (zh) * 2016-12-21 2020-12-29 四川东坡中国泡菜产业技术研究院 一种低盐泡菜微生态添加剂及其制备方法
WO2020178794A1 (en) * 2019-03-07 2020-09-10 Probiotical S.P.A. Mixture of probiotic bacteria strains for use in the treatment of allergic asthma and with recurrent wheezing, preferably in paediatric subjects
CN111567619B (zh) * 2020-06-22 2023-04-14 扬州大学 一种高品质火麻发酵乳的制作方法及其应用
ES3009876A1 (es) * 2023-09-29 2025-03-31 Univ Jaen Cepa Lactiplantibacillus pentosus CECT 30896

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
EP1481681A1 (en) * 2003-05-30 2004-12-01 Claudio De Simone Lactic acid bacteria combination and compositions thereof
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product

Also Published As

Publication number Publication date
CN102458426A (zh) 2012-05-16
CN102458426B (zh) 2014-12-03
AU2010252656A1 (en) 2012-01-12
ES2534750T3 (es) 2015-04-28
BRPI1011277B1 (pt) 2021-03-23
EP2435056B1 (en) 2015-01-28
BRPI1011277B8 (pt) 2021-05-25
JP2012527884A (ja) 2012-11-12
BRPI1011277A2 (pt) 2016-03-22
ITRM20090270A1 (it) 2010-11-28
RU2547599C2 (ru) 2015-04-10
EP2435056A1 (en) 2012-04-04
PL2435056T3 (pl) 2015-06-30
US9185927B2 (en) 2015-11-17
RU2011150659A (ru) 2013-07-10
US20120164119A1 (en) 2012-06-28
AU2010252656B2 (en) 2015-02-05
WO2010136891A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
IT1397566B1 (it) Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso
IL224288A (en) Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
IL216254A (en) Compounds, pharmaceutical compositions and their uses
IL222484A0 (en) Arginase inhibitor compounds, compositions comprising the same and uses thereof
BRPI1005292A2 (pt) composição de decapagem e uso da composição
IL222968A0 (en) Atr kinase inhibitor compounds, compositions comprising the same and uses thereof
IL220563A0 (en) Pteridinone compounds, compositions comprising the same and uses thereof
IT1405432B1 (it) Preparazione alimentare funzionale ed uso relativo.
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112012013148A2 (pt) formulação farmacêutica e uso
IL216768A0 (en) Aminopyrrolidinone derivatives compositions comprising the same and uses thereof
DK2657333T3 (da) Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf
IL226382A0 (en) Integrin agonist compounds, preparations containing them and their uses
BRPI0921699A2 (pt) complexo antioxidante, composicoes cosmeticas e farmaceutica contendo o referido complexo e uso deste complexo
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
IL218490A (en) Oxazolopyrimidinones dihydro hydroxybencyalkyloxymethyl are converted, preparations containing them and their use in the preparation of pharmaceutical preparations
BRPI1005670A8 (pt) composições adjuvantes e processos de uso.
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BRPI1014914A2 (pt) Composição contendo trehalulose, sua preparação e uso
EP2599490A4 (en) COMPOSITION FOR TREATMENT OF INJURY, FORMULATION AND USE THEREOF
IL223405B (en) Phosphoplatins, preparations containing them and their uses
IL219243A (en) History of 5-hydroxypyrimidine-4-carboxamide, preparations containing them and their uses
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
IL215153A0 (en) Amide derivative compounds, compositions comprising the same and uses there of
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载